[Edaily Starin Choi Hee-jae Reporter] In "Dive for You," Park Seo-ham loses his life trying to protect Kim Ji-yeon. (Photo: Channel A, Disney+) The first episode of the new drama “Dive for You,” premiering on Disney+ and Channel A on the 26th, depicts the tragedy of Yoon Ha-na’s (played by Kim Ji-yeon) first love, Jeong Woo-jae (played by Park Seo-ham), losing his life. Yoon Ha-na and Jeong Woo-jae have been inseparable since high school and are each other’s first loves. Following the most sparkling moments of their youth, they remain together today—she as an actress and he as a bodyguard—but over the years, they have never confessed their true feelings or taken a step closer to one another. Amid this, an assailant breaks into the awards ceremony where Yoon Ha-na is in attendance, and Jeong Woo-jae, who was protecting her as her bodyguard, loses his life. The released photos vividly capture the harrowing scene of that day, leaving viewers deeply shaken. Inside the awards ceremony—a festival of stars—Yoon Ha-na, dressed in a glamorous gown, is basking in the joy of winning the Best Actress award. However, Jung Woo-jae meets a tragic end outside Yoon Ha-na’s dressing room. The sight of Yoon Ha-na embracing him and weeping uncontrollably is heart-wrenching. Jung Woo-jae’s death leaves an indelible wound in Yoon Ha-na’s heart and is set to completely upend her acting career. “Dive into You” is a first-love rescue romance drama about twin siblings Yoon Ha-na and Yoon Ha-ru, who discover they can travel back in time using an old camcorder and dive into the past to bring Jeong Woo-jae back to life. It premieres on the 26th at 10:30 p.m.
“The key point in the Jensen Huang scandal will ultimately be that data centers were built in China and elsewhere, and cloud services were provided to Chinese companies. Given the circumstances, this …
Fashion company Shinwon(009270)continues to show improved performance, driven by strong exports. This is attributed to the company’s expansion of its production and sales infrastructure, particularly …
Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…